Phase 3 Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been newly diagnosed with nasopharyngeal carcinoma (a type of head and neck cancer) confirmed by a tissue sample, specifically WHO types II or III
- People of any gender aged between 18 and 65 years old
- People who have a good general level of physical functioning, as measured by a standard performance scale (KPS score of 80 or above)
- People whose cancer is classified as stage III or IVa according to the international cancer staging system (AJCC/UICC 8th edition)
- People without significant diseases of the digestive system, or significant nutritional, metabolic, or hormonal conditions
- People without significant heart, lung, kidney, or liver disease
- People who have not previously received radiotherapy, chemotherapy, immunotherapy, or any other cancer treatment
- People whose blood test results show healthy levels of white blood cells, red blood cells (haemoglobin), and platelets within the ranges required by the trial
- People whose liver function blood tests are within acceptable ranges (below 2.5 times the upper limit of normal)
- People whose kidney function tests are within acceptable ranges
- People who have no medical reasons preventing them from safely receiving chemotherapy or radiotherapy
- People who have given their written informed consent to participate
Who may not be able to join:
- People who have medical reasons that prevent the placement of a feeding tube directly into the stomach or small intestine — for example, blood clotting problems, recent use of blood thinners or aspirin, stomach ulcers or a history of stomach bleeding, certain complications related to liver disease, or specific stomach anatomy resulting from prior major stomach surgery
- People whose cancer has spread to distant parts of the body (metastatic disease)
- People who have had, or currently have, another type of cancer
- People who are already participating in another clinical trial
- People with drug or alcohol dependency
- People who do not have full legal capacity to make decisions for themselves
- People with a mental health disorder
- People who are pregnant or breastfeeding
- People with serious additional health conditions that are not well controlled, such as uncontrolled high blood pressure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chong Zhao, MD, Sun Yat-Sen University Cancer Center
Phone: 86-13631355201
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The incidence of IBW%
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.